Participant flow14

How many started, completed or left each group, period by period.

1 to 14 of 14

Period	Milestone	Group	Participants
12 Months Primary Study	STARTED	Teriparatide	34
12 Months Primary Study	STARTED	Zoledronic Acid	35
12 Months Primary Study	Completed 6 Months Double Blind Phase	Teriparatide	28
12 Months Primary Study	Completed 6 Months Double Blind Phase	Zoledronic Acid	31
12 Months Primary Study	COMPLETED	Teriparatide	27
12 Months Primary Study	COMPLETED	Zoledronic Acid	31
12 Months Primary Study	NOT COMPLETED	Teriparatide	7
12 Months Primary Study	NOT COMPLETED	Zoledronic Acid	4
12 - 24 Months Extension Treatment	STARTED	Teriparatide	10
12 - 24 Months Extension Treatment	STARTED	Zoledronic Acid	11
12 - 24 Months Extension Treatment	COMPLETED	Teriparatide	10
12 - 24 Months Extension Treatment	COMPLETED	Zoledronic Acid	11
12 - 24 Months Extension Treatment	NOT COMPLETED	Teriparatide	0
12 - 24 Months Extension Treatment	NOT COMPLETED	Zoledronic Acid	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00927186/flow